Mexico Influenza Diagnostics Market Size & Outlook
The influenza diagnostics market in Mexico is expected to reach a projected revenue of US$ 30.5 million by 2030. A compound annual growth rate of 3.8% is expected of Mexico influenza diagnostics market from 2024 to 2030.
Revenue, 2023 (US$M)
$23.5
Forecast, 2030 (US$M)
$30.5
CAGR, 2024 - 2030
3.8%
Report Coverage
Mexico
Mexico influenza diagnostics market, 2018-2030 (US$M)
Related Markets
Mexico influenza diagnostics market highlights
- The Mexico influenza diagnostics market generated a revenue of USD 23.5 million in 2023 and is expected to reach USD 30.5 million by 2030.
- The Mexico market is expected to grow at a CAGR of 3.8% from 2024 to 2030.
- In terms of segment, ridt was the largest revenue generating test type in 2023.
- RIDT is the most lucrative test type segment registering the fastest growth during the forecast period.
Influenza diagnostics market data book summary
| Market revenue in 2023 | USD 23.5 million |
| Market revenue in 2030 | USD 30.5 million |
| Growth rate | 3.8% (CAGR from 2023 to 2030) |
| Largest segment | Ridt |
| Fastest growing segment | RIDT |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | RIDT, RT-PCR, Cell Culture |
| Key market players worldwide | 3M Co, Abbott Laboratories, Becton Dickinson & Co, Meridian Bioscience, QuidelOrtho Corp, Roche Holding AG, Sekisui Chemical Co Ltd, Thermo Fisher Scientific Inc, Hologic Inc, SA Scientific |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.4% of the global influenza diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil influenza diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 63.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Influenza Diagnostics Market Scope
Influenza diagnostics market segmentation & scope
Influenza Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico influenza diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to influenza diagnostics market will help companies and investors design strategic landscapes.
Ridt was the largest segment with a revenue share of 31.06% in 2023. Horizon Databook has segmented the Mexico influenza diagnostics market based on ridt, rt-pcr, cell culture covering the revenue growth of each sub-segment from 2018 to 2030.
- Mexico Influenza Diagnostics Test Type Outlook (Revenue, USD Million, 2018-2030)
- RIDT
- RT-PCR
- Cell Culture
- Others
- Mexico Influenza Diagnostics End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- POCT
- Laboratories
Reasons to subscribe to Mexico influenza diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico influenza diagnostics market databook
-
Our clientele includes a mix of influenza diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico influenza diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico influenza diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico influenza diagnostics market size, by test type, 2018-2030 (US$M)
Mexico Influenza Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
